
Thermo Fisher Scientific Inc.
TMO 583.45 (0.00%) 0.00
Health Care
Life Sciences Tools and Services
Quality Checklist 5/8
5Y Shares Out Change < 0%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
ROIC > 10%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $219.21(B)
EV: $251.48(B)
Total Equity: $51.15(B)
Earnings date: Jan-29-2026
P/E: 33.65
Forward P/E: 25.67
P/FCF: 35.86
P/S: 5.06
P/B: 4.30
EPS: $17.3
EPS (fwd): $22.7
FCF/share: $16.3
Revenue/share: $115.4
Book value/share: $135.8
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Debt/Equity: 0.70
Current Ratio: 1.50
Gross margin: 41.4%
Operating margin: 18.4%
Net margin: 15.0%
Dividend/share: $1.7
Div. yield: 0.29%
Growth Estimates
Revenue
CAGR: 5.0%FY+1$44.26(B)
FY+2(+5.1%)$46.52(B)
FY+3(+5.6%)$49.11(B)
FY+4(+5.1%)$51.63(B)
FY+5(+4.0%)$53.70(B)
Net Income
CAGR: 8.8%FY+1$8.60(B)
FY+2(+7.5%)$9.24(B)
FY+3(+8.9%)$10.07(B)
FY+4(+9.2%)$10.99(B)
FY+5(+9.7%)$12.06(B)
EPS
CAGR: 10.9%FY+1$22.73
FY+2(+8.4%)$24.65
FY+3(+10.6%)$27.26
FY+4(+11.8%)$30.48
FY+5(+12.6%)$34.32
FCF per share
CAGR: 14.3%FY+1$17.59
FY+2(+27.7%)$22.47
FY+3(+9.3%)$24.55
FY+4(+8.4%)$26.62
FY+5(+12.7%)$30.00
